Skip to main content
. Author manuscript; available in PMC: 2018 Dec 18.
Published in final edited form as: J Neurol Disord. 2018 Oct 17;6(5):393. doi: 10.4172/2329-6895.1000393

Table 1:

Clinical characteristics of participants.

Demographics CMMOH (16) CM (13) Controls (19)
Age 39 ± 14 39 ± 12 37 ± 11
BMI 26 ± 6 31 ± 4 26 ± 5
Race/Ethnicity
white 10 (62.5) 10 (76.9) 12 (63.1)
black 6 (37.5) 3 (23.1) 7 (36.9)
Highest Degree Completed
Unknown 1 (6.3) 1 (7.7) 1 (5.3)
High School 5 (31.3) 8 (61.5) 4 (21)
Undergraduate 7 (43.8) 2 (15.4) 10 (52.6)
Graduate 3 (18.8) 2 (15.4) 4 (21.0)
Clinical Features CMMOH CM p-value
Moderate to severe HA days/month 21 ± 7 15 ± 5 0.005*
Headache Location
Right 1 (6.3) 2 (15.4) n/a
Left 2 (12.5) 3 (23.1) --
Bilateral 13 (81.3) 8 (61.5) --
Aura 10 (62.5) 5 (38.5) n/a
Cranial autonomic symptoms 8 (5h0.0) 2 (15.4) n/a
Allodynia (ASC12) Score 6 ± 3 5 ± 6 0.22
Family history (1st degree) 13 (81.3) 7 (53.8) n/a
History of migraine (years) 21 ± 13 20 ± 13 0.371
History of CM (years) 2 ± 1 3 ± 3 0.135
Hit-6 Score 67 ± 3 64 ± 4 0.03*
PHQ-9 Score 10 ± 6 5 ± 3 0.006*

Abbreviations: CM=Chronic Migraine; MOH=Medication Overuse Headache; c=controls; BMI=Body Mass Index; HA=Moderate to Severe Headache Days; HIT-6=Headache Impact Test; PHQ-9=Patient Health Questionnaire-9

Values represent mean ± standard deviation or number (% of total).